Your browser doesn't support javascript.
loading
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
Calland, Noémie; Sahuc, Marie-Emmanuelle; Belouzard, Sandrine; Pène, Véronique; Bonnafous, Pierre; Mesalam, Ahmed Atef; Deloison, Gaspard; Descamps, Véronique; Sahpaz, Sevser; Wychowski, Czeslaw; Lambert, Olivier; Brodin, Priscille; Duverlie, Gilles; Meuleman, Philip; Rosenberg, Arielle R; Dubuisson, Jean; Rouillé, Yves; Séron, Karin.
Afiliação
  • Calland N; Center for Infection & Immunity of Lille (CIIL), Inserm U1019, CNRS UMR8204, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France.
  • Sahuc ME; Center for Infection & Immunity of Lille (CIIL), Inserm U1019, CNRS UMR8204, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France.
  • Belouzard S; Center for Infection & Immunity of Lille (CIIL), Inserm U1019, CNRS UMR8204, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France.
  • Pène V; University Paris Descartes, EA 4474, Hepatitis C Virology, Paris, France.
  • Bonnafous P; University Bordeaux, CBMN UMR 5248, Bordeaux INP, Pessac, France.
  • Mesalam AA; Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium.
  • Deloison G; Center for Infection & Immunity of Lille (CIIL), Inserm U1019, CNRS UMR8204, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France.
  • Descamps V; Virology Laboratory, EA 4294, Centre Hospitalier Universitaire d'Amiens, Université de Picardie Jules Verne, Amiens, France.
  • Sahpaz S; Laboratory of Pharmacognosy, EA 4481, Université Lille 2, Lille, France.
  • Wychowski C; Center for Infection & Immunity of Lille (CIIL), Inserm U1019, CNRS UMR8204, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France.
  • Lambert O; University Bordeaux, CBMN UMR 5248, Bordeaux INP, Pessac, France.
  • Brodin P; Center for Infection & Immunity of Lille (CIIL), Inserm U1019, CNRS UMR8204, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France.
  • Duverlie G; Virology Laboratory, EA 4294, Centre Hospitalier Universitaire d'Amiens, Université de Picardie Jules Verne, Amiens, France.
  • Meuleman P; Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium.
  • Rosenberg AR; University Paris Descartes, EA 4474, Hepatitis C Virology, Paris, France.
  • Dubuisson J; Center for Infection & Immunity of Lille (CIIL), Inserm U1019, CNRS UMR8204, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France.
  • Rouillé Y; Center for Infection & Immunity of Lille (CIIL), Inserm U1019, CNRS UMR8204, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France.
  • Séron K; Center for Infection & Immunity of Lille (CIIL), Inserm U1019, CNRS UMR8204, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France karin.seron@ibl.cnrs.fr.
J Virol ; 89(19): 10053-63, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26202241
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepacivirus / Internalização do Vírus / Polifenóis Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepacivirus / Internalização do Vírus / Polifenóis Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article